Part:BBa_K3140002
PsiK - 4-hydroxytryptamine kinase from Psilocybe cubensis
PsiK is a 4-hydroxytryptamine kinase, which catalyses the conversion of 4-hydroxytryptamine to norbaeocystin.
- NCBI: ASU62237.1
- UniProt: P0DPA8
- EC number: 2.7.1.222
Usage and Biology
The mechanism of psilocybin biosynthesis in Psilocybe sp. was recently elucidated by Fricke et al.[1], demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin.
PsiK is a native enzyme obtained from Psilocybe cubensis, which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both 4-hydroxytryptamine and psilocin as substrates to yield norbaeocystin (Fig. 1) and psilocybin (Fig. 2), respectively. In a native state, PsiK is a 362 amino acid protein (40.4 kDa) with a theoretical pI of 5.26 calculated with the ExPASy ProtParam tool[2].
Heterologous expression of PsiK has been achieved in a T7 induction system using pET-28c(+) transformed into Escherichia coli BL21(DE3), co-transformed with chaperone plasmid pGro7 (Fig. 3), resulting in a 397 amino acid polypeptide, with a computed molecular weight of 44.2 kDa.
A band consistent with expression of PsiK in cells induced with IPTG was observed on polyacrylamide gel electrophoresis (Fig. 4).
Activity of PsiK was confirmed with LC/MS. Protein extract from E. coli BL21(DE3) cells co-transformed with pET-28c(+):PsiK and pGro7 was subject to LC/MS, both with and without the addition of the PsiD substrate, 4-hydroxytryptamine. The PsiK product, norbaeocystin, was only identified in the sample to which 4-hydroxytryptamine was added, confirming the activity of PsiK in vitro (Fig. 5).
While norbaeocystin was observed in the sample to which 4-hydroxytryptamine was added (Table 1), it was not observed when 4-hydroxytryptamine was absent (Table 2).
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
1.16 | 0.9 | 257.0687 | C10H14N2O4P | norbaeocystin |
2.63 | 20.7 | 177.1024 | C10H13N2O | hydroxytryptamine |
3.46 | 2.4 | 205.0972 | C11H13N2O2 | tryptophan |
10.14 | 5.1 | 285.1336 | C9H18N8OP | unknown |
10.14 | 5.1 | 285.1336 | C14H21O6 | unknown |
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
10.16 | 11.3 | 285.1336 | C14H21O6 | unknown |
10.16 | 11.3 | 285.1336 | C9H18N8OP | unknown |
In vivo expression of PsiD was also confirmed. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 (Fig. 6). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. E. coli DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS.
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
0.56 | 23.2 | 271.0817 | C12H15O7 | unknown |
1.16 | 12.4 | 257.0689 | C10H14N2O4P | norbaeocystin |
1.9 | 0.9 | 271.0844 | C11H16N2O4P | baeocystin |
2.75 | 5.2 | 177.1023 | C10H13N2O | hydroxytryptamine |
5.08 | 6.4 | 205.0972 | C11H13N2O2 | tryptophan |
5.82 | 6.4 | 161.1074 | C10H13N2 | tryptamine |
10.15 | 14.4 | 285.1335 | C14H21O6 | unknown |
10.15 | 14.4 | 285.1335 | C9H18N8OP | unknown |
The in vivo activity of PsiK is confirmed by observation of PsiK product norbaeocystin (Fig. 7).
Given these results, we conclude that we have successfully expressed the tryptophan decarboxylase PsiD from Psilocybe cubensis in Escherichia coli both in vivo and in vitro.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 864
Illegal SapI.rc site found at 973
References
None |